| The aryl hydrocarbon receptor and the gut–brain axis A Barroso, JV Mahler, PH Fonseca-Castro, FJ Quintana Cellular & molecular immunology 18 (2), 259-268, 2021 | 74 | 2021 |
| Diagnostic tools for neurosyphilis: a systematic review GHP Boog, JVZ Lopes, JV Mahler, M Solti, LT Kawahara, AK Teng, ... BMC Infectious Diseases 21 (1), 568, 2021 | 29 | 2021 |
| Therapeutic induction of tolerogenic dendritic cells via aryl hydrocarbon receptor signaling A Barroso, JV Mahler, PH Fonseca-Castro, FJ Quintana Current Opinion in Immunology 70, 33-39, 2021 | 25 | 2021 |
| Cost, efficacy, and safety comparison between early intensive and escalating strategies for multiple sclerosis: A systematic review and meta-analysis LZ Pipek, JV Mahler, RFV Nascimento, SL Apóstolos-Pereira, GD Silva, ... Multiple Sclerosis and Related Disorders 71, 104581, 2023 | 8 | 2023 |
| Vitamin D3 as an add-on treatment for multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials JV Mahler, M Solti, SL Apóstolos-Pereira, T Adoni, GD Silva, D Callegaro Multiple Sclerosis and Related Disorders, 105433, 2024 | 1 | 2024 |
| Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids (SLIPPERS)—Does it Really Exist? F Freua, JV Mahler, PLGSB Lima, IS Neville, LB Portella, VHR Marussi, ... Brain Sciences 13 (8), 1191, 2023 | 1 | 2023 |
| Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing? GD Silva, JV Mahler, SRP da Silva Junior, LO Mendonça, ... BMC neurology 24 (1), 130, 2024 | | 2024 |
| The myths that drive therapeutic inertia in multiple sclerosis: a cost-effectiveness analysis of high-efficacy drugs in Brazil LZ Pipek, JV Mahler, RFV Nascimento, J Becker, SL Apóstolos-Pereira, ... Arquivos de Neuro-psiquiatria 82 (01), 001-002, 2024 | | 2024 |
| Verbal-memory impairment is associated with widespread white-matter tract involvement in patients with temporal lobe epilepsy and hippocampal sclerosis (S35. 003) JVMF Oliveira, M Solti, C Adda, C Jorge, RM Valerio, K Lyra, B Pastorello, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| White matter tract abnormalities are associated with executive dysfunction in temporal lobe epilepsy and hippocampal sclerosis (P12-1.010) M Solti, JVMF Oliveira, C Adda, R Valerio, C Jorge, K Lyra, B Pastorello, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Cost comparison between early intensive and escalating strategies for multiple sclerosis in Brazil LZ PIPEK, JV MAHLER, RFV NASCIMENTO, SL APóSTOLOS-PEREIRA, ... Galoá, 2023 | | 2023 |
| Should we stop using post-contrast sequences in the follow-up MRI of patients with multiple sclerosis? JV Mahler, GD Silva Journal of the Neurological Sciences 442, 2022 | | 2022 |
| Paraneoplastic AQP-4 IgG negative neuromyelitis optica spectrum disorder (NMOSD) associated with large-cell high-grade undifferentiated carcinoma of unknown primary site: A … JV Mahler, MH de Brito, L Miyahara-Felipe, AS Ayres, HA Araújo, ... Neuroimmunology Reports 2, 100110, 2022 | | 2022 |
